Are you a Medical Practitioner wanting to order BREASTEST plus™ - Click here to find out more

Advancing breast cancer screening
with a non-invasive blood test

Welcome to BCAL Diagnostics

At BCAL Diagnostics Limited (BCAL), we believe early and accurate detection is key to improving breast cancer outcomes. As an Australian biotechnology company, we are pioneering a non-invasive blood test designed to complement existing breast screening methods and provide women with greater confidence in their care.

About us
ASX:BDX ▼ $0.069

1 in 7

Women will receive a breast cancer diagnosis in their lifetime
RCPA
NATA accredited

What is BREASTEST plus™?

BREASTEST plus™ is a first-in-class blood test designed to be used alongside standard mammogram in breast cancer screening.

Developed in partnership with doctors, BREASTEST plus™ provides additional information – particularly for women with dense breasts, to help rule out the presence of breast cancer when imaging alone may be inconclusive. Developed in Australia and backed by global clinical research, BREASTEST plus™ is available via select healthcare professionals.

Call 1300 222 539 to learn more about BCAL products and ongoing research.

1 in 7 Women Will Be Diagnosed with Breast Cancer in Their Lifetime

Source — National Breast Cancer Foundation

Our Mission

For over a decade, BCAL has been committed to developing innovative, accessible technologies that enhance breast cancer screening.

Our mission is to partner with doctors and empower women through early, accurate breast cancer diagnostics, improving outcomes and confidence in care – while delivering long term sustainable growth to shareholders.

Three young women walking barefoot on the beach, enjoying a sunny day. They are dressed in casual outfits, with two wearing white shirts and one in a red polka dot top. The background features lush greenery and calm waters, creating a serene atmosphere.

Designed to Complement Mammography

BREASTEST plus™ is designed to be used alongside mammography, offering additional diagnostic information, particularly for women with dense breast tissue, where imaging can be more challenging.

By complementing traditional screening methods, BREASTEST plus™ supports doctors in assessing breast health to help rule out breast cancer as part of a comprehensive screening approach.

A healthcare professional assists a patient during a mammogram procedure, highlighting the importance of breast cancer screening. The image depicts the patient positioned in front of a mammography machine, with the technician providing guidance and support.

About Us

BCAL is led by a team of experts with deep experience in biotechnology, diagnostics, and healthcare innovation. Our leadership is dedicated to advancing scientific excellence and bringing practical, life-changing solutions to improve health outcomes for women.

Three professionals posing together in a modern office setting, showcasing a confident and approachable atmosphere. The woman on the left wears a light pink dress, while the two men are attired in business suits, one in navy blue and the other in a dark suit with a patterned tie. The background features glass walls and a well-lit interior, emphasizing a professional environment.

Dedicated to Advancing Early Detection

BCAL is committed to transforming breast cancer screening with innovative, non-invasive diagnostic technology. Our mission is to partner with doctors and empower women through early, accurate breast cancer diagnostics, improving outcomes and confidence in care.

Three women walking barefoot on a beach, enjoying a sunny day. They are dressed in casual outfits, with one wearing a red polka dot top and sunglasses. The background features lush greenery and a serene ocean view, capturing a moment of friendship and relaxation.

What We Do

BCAL is advancing non-invasive breast cancer screening with a simple blood test designed to complement existing imaging technologies.

Initially developed to support mammograms, our solutions aim to evolve into a comprehensive screening and monitoring approach for women. Through close partnership with doctors, we empower women with earlier, more accurate breast cancer diagnostics – delivering greater choice and confidence in their breast health journey.

A senior woman in a pink shirt gestures while discussing her health concerns with a healthcare professional during a consultation in a well-lit office setting.

Making An Impact

For over a decade, BCAL has been developing a non-invasive diagnostic tool designed to enhance breast cancer screening – resulting in a simple blood test that complements mammography to rule out breast cancer in women over 30 with high breast density.

Smiling patient engaged in a positive conversation with a healthcare professional in a medical office setting, highlighting the importance of patient care and communication.

“BCAL’s blood test helps to bridge diagnostic gaps where mammography performance is limited, or the imaging is unclear – which is common in women with high breast density. Incorporating this test into routine practice is an important step toward improving early and accurate diagnosis for this group of women.”

Professor Elisabeth Elder
Professor Elisabeth Elder

Specialist Breast and Oncoplastic Surgeon,

Lakeview Private Hospital

Join Our Team in Transforming Breast Cancer Diagnostics

We invite you to take the next step:

  • Discover how BCAL blood test is changing the future of breast cancer as part of a comprehensive screening approach
  • Support our mission by exploring investment opportunities with BCAL Diagnostics (ASX: BDX)

Contact our team today – we’re here to answer your questions, provide more information, or connect you with the right resources.